Agilon Health Inc (NYSE:AGL) price on Tuesday, December 24, rose 3.24% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.91.
A look at the stock’s price movement, the close in the last trading session was $1.85, moving within a range at $1.8106 and $1.92. The beta value (5-Year monthly) was 0.602. Turning to its 52-week performance, $13.28 and $1.50 were the 52-week high and 52-week low respectively. Overall, AGL moved 1.06% over the past month.
Agilon Health Inc’s market cap currently stands at around $812.47 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 1.52B for the company’s revenue for the quarter, with a low and high estimate of 1.51B and 1.53B respectively. The average forecast suggests up to a 43.89% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 6.05B, representing a 40.27% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AGL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 7 recommend AGL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AGL’s current price about -8.68% and -16.29% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.11, while 7-day volatility ratio is 9.07% and 9.60% in the 30-day chart. Further, Agilon Health Inc (AGL) has a beta value of 0.53, and an average true range (ATR) of 0.20. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $2.5 and high of $4. Looking at the price targets, the low is -30.89% off current price level while to achieve the yearly target high, price needs to move -109.42%. Nonetheless, investors will most likely welcome a -57.07% jump to $3 which is the analysts’ median price.
If we refocus on Agilon Health Inc (NYSE:AGL), historical trading data shows that trading volumes averaged 3.47 over the past 10 days and 4.40 million over the past 3 months. The company’s latest data on shares outstanding shows there are 411.96 million shares.
The 26.39% of Agilon Health Inc’s shares are in the hands of company insiders while institutional holders own 80.56% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 31.94 million on 2024-11-29, giving us a short ratio of 6.38. The data shows that as of 2024-11-29 short interest in Agilon Health Inc (AGL) stood at 3065.9999999999995 of shares outstanding, with shares short falling to 36.22 million registered in 2024-10-31. Current price change has pushed the stock -84.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AGL stock continues to rise going into the next quarter.
